Mice lacking p63, a single gene that encodes a group of transcription factors that either contain (TA) or lack (⌬N) a transactivation domain, fail to develop stratified epithelia as well as epithelial appendages and limbs. ⌬Np63 isoforms are predominantly expressed during late embryonic and postnatal epidermal development, however, the function of these proteins remains elusive. Using an epidermal-specific inducible knockdown mouse model, we demonstrate that ⌬Np63 proteins are essential for maintaining basement membrane integrity and terminal differentiation of keratinocytes. Furthermore, we have identified two ⌬Np63␣ target genes that mediate these processes. We propose that ⌬Np63␣ initially induces expression of the extracellular matrix component Fras1, which is required for maintaining the integrity of the epidermal-dermal interface at the basement membrane. Subsequently, induction of IB kinase-␣ by ⌬Np63␣ initiates epidermal terminal differentiation resulting in the formation of the spinous layer. Our data provide insights into the role of ⌬Np63␣ in epidermal morphogenesis and homeostasis, and may contribute to our understanding of the pathogenic mechanisms underlying disorders caused by p63 mutations.
D
uring epidermal morphogenesis, the sequential and coordinated action of transcription factors ultimately results in the formation of a mature epidermis that protects the organism from dehydration and environmental insults (reviewed in ref. 1) . Two critical transitions that occur during normal epidermal morphogenesis are the commitment to stratification, when cells of the single-layered surface ectoderm are induced to become keratinocytes, and the commitment to terminal differentiation. The execution of the terminal differentiation program results in the migration of basal cells to the suprabasal cell layer and is associated with an increase in cellular adhesion, growth arrest, and the induction of biochemical markers of differentiation, such as keratin K1 (reviewed in ref. 2) .
One gene that is critical for controlling epidermal morphogenesis is p63, a transcription factor that can be expressed as isoforms that contain (TA) or lack (⌬N) a transactivation domain (3) . The critical role for p63 in regulating epidermal morphogenesis is illustrated by the phenotype of p63 Ϫ/Ϫ mice, which fail to develop an epidermis, other stratified epithelia, and epithelial appendages (4, 5) . The single layer of epithelial cells covering p63 Ϫ/Ϫ mice at birth fails to provide barrier function, resulting in early postnatal lethality due to severe dehydration. However, despite the striking phenotype of p63 Ϫ/Ϫ mice, the precise role of p63 in epidermal morphogenesis is controversial. Initial reports suggested a role for p63 in epithelial stem cell maintenance (5, 6) . However, the finding that p63 is not enriched in epidermal stem cells challenges this notion (7) (8) (9) (10) . In contrast, we previously demonstrated that TAp63 is required for the commitment to stratification during epidermal morphogenesis, a process that is mediated, in part, by induction of AP-2␥ (11, 12) .
Whereas TAp63 isoforms function during the initial stages of epidermal morphogenesis, the role of ⌬Np63 isoforms, the predominantly expressed p63 isoforms during later stages of epidermal morphogenesis (11, 13) as well as in mature epidermis (3, 14) has remained largely elusive. ⌬Np63␣ is mainly expressed in keratinocytes of the proliferative basal layer, whereas its expression is down-regulated in postmitotic keratinocytes of the suprabasal differentiated layers of mature epidermis (3, 15) . Based on this expression pattern and subsequent in vitro studies, it was proposed that ⌬Np63␣ functions by maintaining the proliferative potential of basal keratinocytes while preventing their premature entry into terminal differentiation (16) (17) (18) . This notion is further supported by recent findings demonstrating that down-regulating ⌬Np63 in human primary keratinocytes causes hypoproliferation (19) . The ability of ⌬Np63 to maintain proliferation is accomplished in part by preventing expression of p21, a cyclin-dependent kinase inhibitor that is required for cell cycle exit during keratinocyte terminal differentiation (19) (20) (21) (22) . ⌬Np63␣ inhibits p21 expression both through direct repression by binding to the p21 promoter (21) and by preventing Notch signaling, an upstream activator of p21 in the epidermis (22, 23) .
In contrast to a role for ⌬Np63␣ in maintaining basal keratinocytes, ⌬Np63␣ also regulates the expression of genes required for keratinocyte terminal differentiation. For example, ⌬Np63␣ directly induces p57Kip2 (24), a cyclin-dependent kinase inhibitor that is induced when keratinocytes undergo terminal differentiation (25) . In addition, ⌬Np63␣ directly represses the expression of genes required for cell cycle progression, including cyclin B2 and cdc2 (26). Finally, ⌬Np63␣ synergizes with Notch to induce K1 expression in primar y keratinocytes (22) .
The contradictory in vitro findings summarized above warranted an in vivo analysis of the role of ⌬Np63␣ in epidermal development and differentiation. To this end, we have generated mice in which ⌬Np63 expression can be down-regulated specifically in the epidermis. Surprisingly, we found that downregulating ⌬Np63 isoforms caused severe epidermal defects, including impaired terminal differentiation and impaired basement membrane formation, culminating in the development of severe skin erosions. Furthermore, we found that these defects were caused in part by a failure of ⌬Np63␣ to induce expression of two previously uncharacterized ⌬Np63␣ target genes, Fras1
and IB kinase-␣ (Ikk␣), which are required for maintaining basement membrane integrity and terminal differentiation, respectively.
Results and Discussion
To determine the role of ⌬Np63 in epidermal development and differentiation, we generated an inducible epidermal-specific ⌬Np63 knockdown (i-kd) mouse model. To this end, we cloned an inverted repeat corresponding to exon 3Ј (E3Ј), the only exon unique to ⌬Np63, into the pDECAP vector (27) (pD-E3Ј). The resulting E3Ј dsRNA transcript was predicted to be processed into ⌬Np63-specific siRNAs in the nucleus. Indeed, cotransfection of cells with a ⌬Np63␣ expression construct and increasing amounts of pD-E3Ј resulted in a dose-dependent decrease in ⌬Np63␣ protein expression (Fig. 1A) . Because E3Ј dsRNA could efficiently down-regulate ⌬Np63␣ expression in vitro, we placed the pD-E3Ј construct under control of our previously described RU486-regulatable gene-switch system (11) . By using this system, expression of pD-E3Ј could be induced in the basal layer of the epidermis by topical application of the progesterone antagonist RU486 (Fig. 1B) . In three independent transgenic lines, topical application of RU486 for 4 days led to a down-regulation of endogenous ⌬Np63, but not TAp63, expression in the skin [ Fig. 1 C and D and supporting information (SI) Fig. 5 ].
The mouse line with the most efficient ⌬Np63 knockdown (J5107) was subsequently used for all experiments and is referred to as ⌬Np63 i-kd. Importantly, ⌬Np63␣ is the predominantly expressed ⌬Np63 isoform in mature skin, whereas ⌬Np63␤ and ⌬Np63␥ are not detectable (3, 14) , therefore, down-regulating ⌬Np63 expression allowed us to analyze the role of ⌬Np63␣ in epidermal morphogenesis and homeostasis. Surprisingly, topical treatment of newborn ⌬Np63 i-kd mice with RU486 for 4 days led to severe skin fragility characterized by multiple skin erosions ( Fig. 2A) . Histologically, these erosions appeared as areas of the skin where the epidermis was completely missing (Fig. 2B) . Furthermore, ⌬Np63 i-kd mice displayed an impaired ability to heal full-thickness skin wounds. Whereas full-thickness wounds completely healed after 96 h in adult control mice, wounds in ⌬Np63 i-kd mice failed to heal and showed only marginal formation of a migrating epithelial tongue (Fig. 2C ). Despite the skin fragility, TUNEL analysis demonstrated that the apoptotic index was unchanged in ⌬Np63 i-kd skin (Fig. 2D ). Downregulating ⌬Np63 also resulted in a failure of keratinocytes to undergo terminal differentiation. First, using a BrdU incorporation assay, we found that suprabasal keratinocytes in ⌬Np63 i-kd epidermis failed to withdraw from the cell cycle (Fig. 2E) . Second, down-regulating ⌬Np63 resulted in a failure of suprabasal keratinocytes to initiate expression of markers of terminal differentiation, including K1 (Fig. 2F) , and loricrin and filaggrin [see SI Fig. 6 ]. In addition, persistent down-regulation of ⌬Np63, achieved by chronically treating adult ⌬Np63 i-kd mice with RU486, resulted in basement membrane abnormalities as demonstrated by discontinuous staining for collagen IV, a marker for the basement membrane ( Fig. 2G and SI Fig. 6 ). The impaired terminal differentiation and the basement membrane abnormalities may have contributed to the observed skin fragility of ⌬Np63 i-kd mice by failing to provide the epidermis with adequate structural stability.
Based on these and published data, we propose that ⌬Np63␣ induces the expression of genes that control basement membrane formation and terminal differentiation, including genes required for cell cycle withdrawal and for the induction of markers of terminal differentiation. To identify in vivo target genes of ⌬Np63 that control these processes, we mimicked the switch from TA-to ⌬Np63 isoforms that occurs during epidermal development. Primary keratinocytes from inducible TAp63␣ mice (11) were treated with RU486 to induce TAp63␣ expression (TAp63:⌬Np63 Ϸ 5:1) and cells were transduced with adenoviruses expressing ⌬Np63␣ (Ad-⌬Np63␣) or GFP (Ad-GFP), following RU486 withdrawal (⌬Np63:TAp63 Ϸ 50:1). Using microarrays (Affymetrix, Santa Clara, CA) and real-time RT-PCR validation, we found that Ikk␣, but not Ikk␤ or Ikk␥, mRNA was up-regulated Ϸ9-fold 12 h after transduction with Ad-⌬Np63␣ (Fig. 3A) . In addition, Ikk␣ mRNA was decreased in ⌬Np63 i-kd epidermis (Fig. 3B) , further suggesting that ⌬Np63␣ could regulate Ikk␣ expression. p63 regulates gene expression by interacting with degenerate p53 response elements (p53RE) (28, 29) , one of which (p53RE-Ikk␣) is present in the Ikk␣ promoter (SI Fig. 7 ). To determine whether ⌬Np63␣ could interact with this element in the developing epidermis, we performed ChIP assays on WT skin isolated from embryonic day (E)15.5 embryos, the developmental stage when commitment to terminal differentiation occurs and when ⌬Np63␣ is the predominantly expressed p63 isoform (Fig. 3C) . Immunoprecipitation with a p63␣ antibody resulted in increased recovery of promoter fragments containing p53RE-Ikk␣, demonstrating that ⌬Np63␣ directly binds to the Ikk␣ promoter (Fig. 3D) . Furthermore, ⌬Np63␣ could transactivate a reporter construct containing p53RE-Ikk␣, but not reporter constructs that harbor mutations in p53RE-Ikk␣ (p53RE-Ikk␣-mut1 and p53RE-Ikk␣-mut2) (Fig. 3E) . A recent study, using in vitro experiments, suggested that induction of IKK␣ by ⌬Np63␣ occurs through an indirect mechanism in Saos2 cells (30) . However, our in vivo analyses clearly demonstrate that, when commitment to terminal differentiation occurs, ⌬Np63␣ induces Ikk␣ expression by directly interacting with the Ikk␣ promoter. Although Ikk␣ ϩ/Ϫ mice do not display an overt skin phenotype (31) (32) (33) , the relatively modest reduction (Ϸ60%) in Ikk␣ expression in ⌬Np63 i-kd mice suggests that, in conjunction with reduced expression of other ⌬Np63␣ target genes, reduced Ikk␣ expression has profound effects on epidermal biology. Alternatively, patchy transgene expression could have resulted in varying degrees of ⌬Np63 , and consequently Ikk␣, down-regulation. A more efficient ⌬Np63 knockdown in certain areas may also explain the focal nature of Fig. 1 . In vitro ⌬Np63 knockdown. Mouse exon 3Ј, the only exon unique to ⌬Np63, was subcloned into pDECAP as an inverted repeat (pD-E3Ј). (A) Western blot analysis of Ptk2 cells transfected with a ⌬Np63␣ expression construct (1 g) and increasing amounts of pD-E3Ј (1, 3, and 5 g) by using an anti-p63 (mAb4A4) antibody. Anti-K18 was used as a loading control. The pD-E3Ј construct was placed under control of an RU486 regulatable system to generate ⌬Np63 inducible-knockdown (i-kd) mice. (B) RT-PCR for the pD-E3Ј transgene on RNA isolated from newborn ⌬Np63 i-kd and control skin after 4 days of RU486 treatment. GAPDH was amplified as an internal control. (C) Real-time RT-PCR and (D) Western blot analysis for ⌬Np63/⌬Np63␣ using RNA or protein isolated from the skin of newborn ⌬Np63 i-kd and control littermates that were treated with RU486 for 4 days. the skin erosions, which presumably developed in areas with the most efficient ⌬Np63 down-regulation.
Interestingly, Ikk␣ Ϫ/Ϫ mice and p63 Ϫ/Ϫ mice display similar developmental defects, although skin and appendage development arrest at a later stage in Ikk␣ Ϫ/Ϫ than in p63 Ϫ/Ϫ mice (4, 5, 31-33). As proposed for p63 Ϫ/Ϫ mice, the developmental defects affecting epithelial appendages in Ikk␣ Ϫ/Ϫ mice were demonstrated to be caused by an aborted epidermal differentiation program (34) . To further define the role of IKK␣ in epidermal morphogenesis, we characterized the embryonic skin phenotype of Ikk␣ Ϫ/Ϫ mice and found that Ikk␣ Ϫ/Ϫ mice fail to develop a mature spinous layer. Instead, the intermediate cell layer, a transiently existing suprabasal cell layer, which contains K1-expressing proliferating cells (35, 36) (SI Fig. 8 ), persists as shown by the presence of proliferating cells in the suprabasal layers of E15.5 and E16.5 Ikk␣ Ϫ/Ϫ epidermis (Fig. 3G) . Together with our finding that Ikk␣ expression levels peak at E15.5 (Fig.  3F ), these data demonstrate that IKK␣ is required for maturation of intermediate cells into spinous cells. Unlike ⌬Np63 i-kd epidermis, Ikk␣ Ϫ/Ϫ epidermis expresses certain genes required for epidermal maturation, including K1. Therefore, induction of additional ⌬Np63␣ target genes, which remain to be identified, is likely to be required for maturation of the spinous layer.
Furthermore, although Ikk␣ is a critical target gene of ⌬Np63␣, ⌬Np63 i-kd epidermis not only fails to undergo terminal differentiation, it also fails to establish a functional basement membrane, suggesting that ⌬Np63 induces the expression of genes required for basement membrane formation. To identify ⌬Np63 target genes that function independent of IKK␣, we performed microarray analyses on skin RNA isolated from ⌬Np63 i-kd and control mice, and from Ikk␣ Ϫ/Ϫ and control mice. By performing a comparative analysis of the two sets of microarray data, we identified 51 genes that were specifically down-regulated in ⌬Np63 i-kd skin. Among these was the gene encoding Fras1, a keratinocyte-produced extracellular matrix protein which forms a protein complex with its family members Frem1 (Fras1-related ECM protein 1) and Frem2 (Fras1-related ECM protein 2) (37). The absence of any one of these proteins results in a failure of this protein complex to form, causing a severe embryonic blistering phenotype in mice (37) (38) (39) (40) . Indeed, real-time RT-PCR analysis confirmed that Fras1 was downregulated in ⌬Np63 i-kd skin (Fig. 4A ). In addition, we found that ⌬Np63␣ could induce Fras1 expression in primary keratinocytes (Fig. 4B) . To determine whether ⌬Np63␣ could bind to the Fras1 promoter, we performed ChIP analysis on embryonic skin isolated at E11.5, a developmental stage when Fras1 is highly expressed (Fig. 4D) . Immunoprecipitation demonstrated that ⌬Np63␣ directly interacts with a region of the Fras1 promoter located Ϸ1500 bp 5Ј from the translation start site (Fig. 4C) . In addition, ⌬Np63␣ could transactivate a reporter construct that contained this promoter region (Fig. 4E) . Therefore, ⌬Np63␣ controls basement membrane formation and maintenance by directly inducing Fras1 expression. The importance of Fras1 for maintaining skin integrity suggests that its down-regulation may have contributed to skin fragility in ⌬Np63 i-kd mice.
In summary, by down-regulating ⌬Np63 expression in vivo, we demonstrate that ⌬Np63␣ is required for the initiation of multiple pathways required for epidermal morphogenesis and homeostasis, including terminal differentiation and basement membrane integrity. Furthermore, we have identified two key genes that contribute to epidermal morphogenesis and are controlled by ⌬Np63␣. Initially, ⌬Np63␣ induces expression of the extracellular matrix component Fras1, which is required for basement membrane integrity. During later stages of epidermal morphogenesis, ⌬Np63␣ directly induces IKK␣ resulting in the formation of the spinous layer. In addition to providing insights into the regulation of epidermal morphogenesis, these findings may provide insight into the molecular etiology of ectodermal dysplasias that are caused by p63 mutations.
Materials and Methods
Cell Culture. Primary keratinocytes were isolated from newborn mice and cultured as described (41) . Ptk2 (rat kangaroo kidney) cells were grown and transfected as described (11) . Cells were harvested for Western blot analysis 48 h after transfection.
Fig. 4.
Fras1 is a direct transcriptional target of ⌬Np63␣. Real-time RT-PCR analysis for Fras1 on (A) RNA isolated from newborn ⌬Np63 i-kd and control skin treated for 4 days with RU486 and (B) RNA isolated from primary keratinocytes after a switch in p63 isoform expression from TA-to ⌬Np63. (C) ChIP on E11.5 mouse skin using an anti-p63␣ antibody and primers surrounding p53RE-Fras1. Anti-K14 antibody was used as a negative control. (D) Realtime RT-PCR for Fras1 on RNA isolated from embryonic skin at various developmental stages. (E) A reporter construct (0.5 g) containing p53RE-Fras1 was transfected with or without a ⌬Np63␣ expression vector (0.5 g). Error bars represent standard deviations of A, B, and D (three independent samples) or E (three independent experiments). Transgenic Mouse Lines. To generate the inducible ⌬Np63 knockdown transgene, exon 3Ј of mouse ⌬Np63 was cloned as an inverted repeat separated by a short spacer into pDECAP (pD-E3Ј) (27) . The pD-E3Ј construct was subcloned into the UAS-TK vector. Transgenic mice were generated by standard techniques. Founders were identified by tail-tip DNA PCR analysis using primers FW 5Ј-GGT CGA AGC GGA GTA CTG TC and RV 5Ј-CAC ACC TCC CCC TGA ACC T. Mice carrying the inducible pD-E3Ј transgene were mated with K14.Glp65 mice (42) to generate ⌬Np63 i-kd mice. To induce transgene expression, mice were treated daily with 1 mg/ml RU486 in 100% ethanol (Mifepristone; BioMol, Plymouth Meeting, PA). Transgene induction was confirmed by RT-PCR using primers FW 5Ј-CGC TTC GAG CAG ACA TGA TA and RV 5Ј-CCC CCT GAA CCT GAA ACA TA. GAPDH was amplified as a control by using primers FW 5Ј-AAG GTC GGT GTG AAC GGA TT and RV 5Ј-TGG TGG TGC AGG ATG CAT TG. Three independent transgenic lines, with varying ⌬Np63 knockdown efficiencies, were established.
Wound Healing. Six adult ⌬Np63 i-kd and control mice were treated with 1 mg/ml RU486 for 7 days. On day 8, a 3-mm full-thickness wound was generated on the head by using a punch biopsy (Miltex, York, PA). After 96 h, wounds were excised and fixed in 10% neutral buffered formalin. Histological analysis was performed to confirm that all mice were in the same phase of the hair cycle.
Real-Time RT-PCR. Relative gene expression levels were determined by real-time RT-PCR. RNA was isolated by using RNeasy kits (Qiagen, Valencia, CA), and cDNA was prepared by using the High-capacity cDNA Archive kit (Applied Biosystems, Foster City, CA). Assays-on-Demand TaqMan probes for Ikk␣, Ikk␤, Ikk␥, and Fras1 were obtained from Applied Biosystems. TaqMan primer and probe sequences for ⌬Np63 were: FW 5Ј-GAA AAC AAT GCC CAG ACT CAA, RV 5Ј-TGT GCG TGG TCT GTG TTG, and 6FAM-TGA GCC ACA GTA CAC GAA CCT GGG and for TAp63: FW 5Ј-TGT ATC CGC ATG CAA GAC T, RV 5Ј-CTG TGT TGT AGG GGC TGG TGG AC, and 6FAM-ACC TCA GTG ACC CCA TGT GGC C. TaqMan Universal PCR Master Mix (Applied Biosystems) was used for PCR amplification of cDNA with the Opticon2 System (MJ Research, Tokyo, Japan). Each mRNA was normalized to the level of 18S RNA in each sample, and the relative level of each mRNA was determined by the comparative C T method.
Western Blot Analysis. Protein was extracted from whole skin or transfected cells and subjected to Western blotting using a mouse anti-p63 (4A4) antibody (3). After incubation with an HRPconjugated anti-mouse secondary antibody (Sigma, St. Louis, MO), protein bands were visualized by using SuperSignal West Pico Substrate (Pierce, Rockford, IL). Antibodies against K18 (Sigma) and K14 (41) were used as loading controls.
ChIP. ChIP was performed on skins isolated from 60 E11.5 embryos or 20 E15.5 embryos. After homogenization, dissociated cells were fixed in 1% formaldehyde. After washing and sonication, chromatin was immunoprecipitated with 3 g of either anti-p63␣ (H129; Santa Cruz Biotechnology, Santa Cruz, CA) or anti-K14 antibodies (41) . Immunoprecipitated samples were analyzed by PCR using primers surrounding p53RE-Ikk␣: FW 5Ј-TCC TGG AAT CAC CCT GGA TTG and RV 5Ј-AAT AGG AAC CGA CGC ACG ATG or p53RE-Fras1: FW 5Ј-GTC TTA AGT TAC TCC TAG TCA GTG GTG and RV 5Ј-TTG GAT GGA ACC TGA GTC CT. GAPDH was amplified as control to confirm equal genomic DNA content in the immunoprecipitated samples by using primers FW: 5Ј-CCA ATG TGT CCG TCG TGG AT and RV: 5Ј-TGC TGT TGA AGT CGC AGG AG.
Reporter Gene Assays. Fragments of the Ikk␣ and Fras1 promoters containing degenerate p53RE (p53RE-Ikk␣ and p53RE-Fras1 respectively) were cloned into pGL3-basic (Promega, Madison, WI) which was modified to include the SV40 minimal promoter or TATA box, respectively. Mutations in p53RE-Ikk␣ were generated by using the QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA). In mutant 1, the core sequences (underlined in SI Fig. 7 ) were changed to GCCG and CCCG, whereas in mutant 2, the core sequences were changed to ATTT and AAAT. Ptk2 cells were cotransfected with reporter constructs (0.5 g), a TAp63␣ or ⌬Np63␣ expression construct (0.5 g) and a pCMV-␤gal plasmid (50 ng) as described (11) . Cells were harvested 48 h later, and luciferase assays were performed by using the dual-light combined reporter gene assay system for detection of luciferase and ␤-galactosidase (Applied Biosystems). Average reporter gene activities and standard deviations were determined based on three independent experiments.
In Vivo BrdU Incorporation and Immunofluorescence. Mice were injected i.p. with 250 g/g BrdU (Sigma) in 0.9% sterile saline solution. After 1 h, tissue was fixed in 10% neutral buffered formalin. Primary antibodies used for immunofluorescence were FITC anti-BrdU (Becton Dickinson, Franklin Lakes, NJ), guinea pig anti-K14 (41), rabbit anti-K1 (41), and rabbit anti-collagen IV (Progen, Heidelberg, Germany). Secondary antibody conjugates used were Alexa-conjugated fluorochromes (Invitrogen, Carlsbad, CA).
TUNEL Analysis. TUNEL analysis was performed by using the DeadEnd Fluorometric TUNEL System (Promega) according to the manufacturer's instructions. Sections were counterstained with propidium iodide (Sigma).
All experiments involving mice were performed under Institutional Animal Care and Use Committee approval (Protocol number AN-546).
